Safety and efficacy of microbiota-directed adjunctive therapy in acute pancreatitis: a systematic review and meta-analysis of prebiotics, probiotics, and synbiotics
Ji Sun, Jun Zheng, Ye Shen · 2026
Read Safety and efficacy of microbiota-directed adjunctive therapy in acute pancreatitis: a systematic review and meta-analysis of prebiotics, probiotics, and synbiotics by Ji Sun, Jun Zheng, Ye Shen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13612259.txt.
Description
Ji Sun, Jun Zheng, and Ye Shen pool the trials of gut-directed add-ons for acute pancreatitis. Prebiotics, probiotics, and their combination, synbiotics, have all been proposed to calm this pancreatic inflammation, yet benefit and safety stayed uncertain. Their review searched five databases plus grey sources through mid-2026 and kept thirty studies, twenty-five entering meta-analyses of recovery and harm.
Patients receiving the add-ons left hospital sooner, by 4.68 days on average, though studies disagreed enormously. Total infections fell clearly. Mortality looked lower in the main analysis but lost significance when fragile studies were removed. Pancreatic necrosis infection, organ failure, surgery need, and systemic inflammation did not improve. Safety reporting was patchy, and one large trial warned against live probiotics in predicted severe disease. The authors advise against routine use, above all live preparations in severe disease.
Catalog record
| CREATOR | Ji Sun, Jun Zheng, Ye Shen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |